'truffle' Tag
-
Carmat captures investors’ hearts in its successful IPO
July 7, 2010Truffle’s portfolio company Carmat SAS, a French company that’s developing an artificial heart, successfully completed an IPO yesterday above its target. The IPO will allow the company, founded in 2008, to complete pre-clinical trials on the artificial heart and start testing the device on humans. The implantable organ closely resembles a human heart, featuring right […]
-
Another week, another IPO
April 21, 2010Well, it’s been a productive week for Truffle’s life science team. After successful completion of the Neovacs IPO last thursday, today was portfolio company Deinove’s day in the sun. Deinove develops breakthrough technologies which leverage the natural biodiversity and robustness of deinococcus bacteria (existing on Earth for over 3 billion years) to produce bioethanol from […]
-
Truffle Capital’s Neovacs successfully completes its IPO
April 15, 2010Today represents a milestone for Truffle Capital. Our portfolio company Neovacs successfully completed an IPO on NYSE Euronext Paris. This is significant because it represents Truffle’s first IPO in the biotech sector and portends favorably for the public markets. Neovacs is a biotechnology company focused on an active immunotherapy technology platform with applications in autoimmune […]
-
Our scope and our sweet spot
December 29, 2009Between my partner and I, we receive 500~1000 investment opportunities per year. Of course, we do not invest in all but a few of these annually, if even that. Still, I value the chance to review this deal flow and appreciate the passion and effort put in by every entrepreneur. A significant percentage of our […]